Carregant...
New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
Although the overall survival rate of papillary or follicular thyroid cancers is good, anaplastic carcinomas and radio iodine refractory cancers remain a significant therapeutic challenge. Galectin-1 (Gal-1) is overexpressed in tumor cells and tumor-associated endothelial cells, and is broadly impli...
Guardat en:
| Publicat a: | Cells |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147933/ https://ncbi.nlm.nih.gov/pubmed/34063063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10051112 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|